Fate Therapeutics Inc (FATE) — Free Cash Flow Generation Index
Latest as of June 2020:
0.98x
Fate Therapeutics Inc (FATE) has a Free Cash Flow Generation Index of 0.98x as of June 2020. Free cash flow of $38.20 Million represents 1% of operating cash flow ($38.84 Million). Explore capital reinvestment ratio of Fate Therapeutics Inc to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
0.98x
Free Cash Flow / Operating CF
Free Cash Flow
$38.20 Million
USD
Operating Cash Flow
$38.84 Million
USD
Capital Expenditures
$636.00K
USD
Annual Free Cash Flow Generation for Fate Therapeutics Inc (None–None)
Year-by-year Free Cash Flow Generation Index for Fate Therapeutics Inc. Check total reinvestment intensity of Fate Therapeutics Inc to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).